Original Article: Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion (ESCAPE-MeVO) nej.md/40LTUaL
Editorial: Medium- and Distal-Vessel Occlusion — The Limit of Thrombectomy? nej.md/40Hu9bP@AHAScience | #ISC25
ALT A chart of the distribution of scores on the modified Rankin scale at 90 days (intention-to-treat population)
Anterior Choroidal Artery territory ⬇️⬇️
important as strokes here may be caused by
✨cardioembolism
✨distal ICA steno-occlusive disease
⚠️Not just the typical small vessel that defines other deep territory strokes
Cool video map from @StrokeAHA_ASAahajournals.org/doi/10.1161/…
#STROKE: This Advances in Stroke article by @NguyenThanhMD et al. discusses the latest advances and emerging trends in 2023 and 2024 that inform the triage, interventional, and hemorrhagic realms of patient stroke care. #AHAJournalsahajournals.org/doi/full/10.…
1/11
Neurological complications post-transplant are very important for #neurohospitalists and 🧠#residents who see these consults in 🏥. These complications occur in 10-30% of organ and HSCT recipients!! While often multifactorial, immunosuppressants are major contributors.
Pleased to share the final version of the Canadian Best Practice Guidelines for Cerebral Venous Thrombosis. Many thanks to an outstanding multidisciplinary team of experts who provided unique perspectives on this complex disease. doi.org/10.1017/cjn.2024.269
Do you know the signs of stroke? Students at Thorncliffe Park Public School (@TPPS_TDSB) do! Dr. Manav Vyas, neurologist at St. Michael's Hospital, visited the school to teach the kids to be FAST (face, arms, speech, time) heroes!🦸♀️@fast_heroes@CTVTorontotoronto.ctvnews.ca/video/c29…
🧵#STROKE: The DECOMPRESS-2 prospective, observational, cohort study evaluated clinical outcomes in patients with cerebral venous sinus thrombosis who underwent decompressive hemicraniectomy.
This is part of an excellent thread on under-recognized complications of drug therapy. The interaction below is mechanistically fascinating and applies to all carbapenems.
7. Meropenem (M) use in a pt receiving valproic acid (VPA) can lead to rapid ⬇️ in VPA levels within a few days & precipitate seizures. Even after stopping M, VPA levels may take 1-2 wks to recover. The interaction is so strong that M has been used to treat VPA overdose!
New resource to disseminate to those of you in primary care (and beyond since everyone who sees patients also sees people with migraine). It does not replace a headache consult but it’s a great starting point for those who can be managed in primary care or those who are waiting to see a specialist!
@CanHeadacheSoc
The CHS is excited to share a recently developed clinical guidance document for #primarycare physicians on #migraine management.
This resource can be downloaded on our website at: headachesociety.ca/copy-of-c…
A helpful guide for providers managing patients with cervical artery dissection. Grateful for @AHAScience for commissioning this statement and for all the support they provided. Also grateful for being part of this incredible co-author team. #stroke#CADahajournals.org/doi/10.1161/…
Key Point 1 from the article Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases by Dr. Aaron Izenberg from the October Peripheral Nerve and Motor Neuron Disorders issue, which is available to subscribers at bit.ly/3RoZkoL. #ALS#Neurology#NeuroTwitter#MedEd
ATRESIA Take Home Points by Dr. Christine Albert: NOACs significantly reduce the risk of a combined endpoint of stroke and systemic embolism in CIED pt with AHRE of < 24 hrs by ~ 37%, NNT (=250) to prevent one stroke is substantial @AHAScience@StrokeAHA_ASA#AHA23